(KNSA) Kiniksa Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Kiniksa Pharmaceuticals | (KNSA) share price targets
Complete technical analysis of Kiniksa Pharmaceuticals (KNSA) by charts plus indicators, forecast predictions and share price targets for Kiniksa Pharmaceuticals (KNSA)
Kiniksa Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Kiniksa Pharmaceuticals is 600390
Date | Daily Closing Price | Open | High | Low | Volume |
16 Wed Jul 2025 | 28.42 | 28.38 | 28.96 | 28.30 | 0.566 times |
15 Tue Jul 2025 | 28.09 | 28.71 | 28.89 | 27.95 | 0.674 times |
14 Mon Jul 2025 | 28.80 | 28.26 | 29.07 | 28.17 | 0.677 times |
11 Fri Jul 2025 | 28.09 | 28.74 | 28.74 | 27.92 | 0.592 times |
10 Thu Jul 2025 | 28.95 | 28.77 | 29.09 | 28.50 | 0.594 times |
09 Wed Jul 2025 | 28.80 | 27.71 | 29.25 | 27.50 | 1.514 times |
08 Tue Jul 2025 | 27.21 | 27.76 | 28.16 | 27.06 | 1.06 times |
07 Mon Jul 2025 | 27.95 | 27.58 | 28.17 | 27.30 | 1.213 times |
03 Thu Jul 2025 | 27.88 | 27.50 | 27.92 | 27.12 | 0.929 times |
02 Wed Jul 2025 | 27.44 | 27.25 | 27.97 | 26.89 | 1.577 times |
My analysis of stock is bullish for shortterm, and stock might move up till 28.7 or till 29.3. Use a stoploss of 28.18 and if this stock hits its stoploss, then it can fall down till 27.65
Share price targets for Kiniksa Pharmaceuticals (KNSA)
Target Type | Value |
Downside Target | 18.26 |
Downside Target | 20.39 |
Downside Target | 24.31 |
Downside Target | 24.85 |
Downside Target | 26.54 |
Upside Target | 28.52 |
Upside Target | 28.53 |
Upside Target | 28.56 |
Upside Target | 29.07 |
Upside Target | 29.25 |
Upside Target | 29.29 |
Upside Target | 30.69 |
Intraday share price targets for Kiniksa Pharmaceuticals (KNSA)
Target Type | Value |
Downside Intraday Target | 27.89 |
Downside Intraday Target | 27.36 |
Upside Intraday Target | 29.01 |
Upside Intraday Target | 29.6 |
Upside Intraday Target | 28.48 |
Weekly technical analysis of Kiniksa Pharmaceuticals (KNSA)
Date | Weekly Closing Price | Open | High | Low | Volume |
16 Wed Jul 2025 | 28.42 | 28.26 | 29.07 | 27.95 | 0.385 times |
11 Fri Jul 2025 | 28.09 | 27.58 | 29.25 | 27.06 | 0.945 times |
03 Thu Jul 2025 | 27.88 | 28.51 | 28.53 | 26.89 | 0.285 times |
27 Fri Jun 2025 | 28.04 | 28.61 | 29.29 | 27.91 | 6.374 times |
20 Fri Jun 2025 | 28.44 | 28.15 | 28.52 | 27.62 | 0.431 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Kiniksa Pharmaceuticals (KNSA)
Date | Monthly Closing Price | Open | High | Low | Volume |
16 Wed Jul 2025 | 28.42 | 27.55 | 29.25 | 26.89 | 0.282 times |
30 Mon Jun 2025 | 27.67 | 27.54 | 30.69 | 26.54 | 2.127 times |
30 Fri May 2025 | 27.36 | 26.78 | 28.56 | 24.85 | 0.701 times |
30 Wed Apr 2025 | 26.97 | 22.08 | 27.53 | 18.26 | 1.168 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Kiniksa Pharmaceuticals (KNSA)
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Kiniksa Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Kiniksa Pharmaceuticals in short term but the sell signal is initial and weak.
Kiniksa Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Kiniksa Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Kiniksa Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 28.08 and Kiniksa Pharmaceuticals (KNSA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Kiniksa Pharmaceuticals (KNSA) stock. Volume based technical analysis of Kiniksa Pharmaceuticals (KNSA) stock is negative.
Kiniksa Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Kiniksa Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Kiniksa Pharmaceuticals in short term but the sell signal is initial and weak.
Kiniksa Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Kiniksa Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Kiniksa Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 28.08 and Kiniksa Pharmaceuticals (KNSA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Kiniksa Pharmaceuticals (KNSA) stock. Volume based technical analysis of Kiniksa Pharmaceuticals (KNSA) stock is negative.
Kiniksa Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.